Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × apixaban × Classical hematology × Clear all

Phase

Phase 3 5 Phase 2 4 Phase 4 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Classical hematology 1

Conditions

Venous Thromboembolism 1

Interventions

fludarabine phosphate 12 Cyclosporine 8 Whole-Body Irradiation 7 Peripheral Blood Stem Cell Transplantation 7 Mycophenolic Acid 7 Cyclophosphamide 6 Tacrolimus 4 Filgrastim 4 Cytarabine 4 Carboplatin 4 Azacitidine 4 olaparib 3 Etoposide 3 Biopsy 3 venetoclax 2 tipifarnib 2 peginesatide 2 laromustine 2 hematide 2 enasidenib 2 alvocidib 2 aldesleukin 2 Vorinostat 2 Thiotepa 2 Specimen Handling 2 Sirolimus 2 Rituximab 2 Nivolumab 2 Methylprednisolone 2 Melphalan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03083782 2017-10-11

ACT

Thomas Jefferson University

Phase 1 Completed

Classical hematology

Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡